Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nicholas James Cummings"'
Autor:
Nicola E. Potter, Manohursingh Runglall, Adam Ivey, Anthony P. Schwarer, Kavita Raj, Phillip C. Nguyen, Nigel H. Russell, Chun Yew Fong, Annie‐Louise Latif, Andrew H. Wei, Tse-Chieh Teh, Andrew Grigg, Nicholas James Cummings, Ing Soo Tiong, Richard Dillon, David Taussig
Publikováno v:
British Journal of Haematology
Summary Based on promising results in older adults with acute myeloid leukaemia (AML), we treated patients with NPM1 mut measurable residual disease (MRD) using off‐label venetoclax in combination with low‐dose cytarabine or azacitidine. Twelve c
Autor:
Chung H. Kok, Grant A Engler, Richard J D'Andrea, Sonya M. Diakiw, Anna L. Brown, Nicholas James Cummings, Ian D. Lewis, Andrew H. Wei, Michelle Perugini, L B To
Publikováno v:
British Journal of Haematology. 161:884-888
Sonya M. Diakiw, Michelle Perugini, Chung H. Kok, Grant A. Engler, Nik Cummings, Luen Bik To, Andrew H. Wei, Ian D. Lewis, Anna L. Brown, Richard J. D’Andrea
Autor:
Dean Yee, Hayley S. Ramshaw, Erwin M. Lee, Richard B. Lock, Jason A. Powell, Andrew H. Wei, Nicholas James Cummings, Ian D. Lewis, Julie McManus, Martin N. McCall, Angel F. Lopez, Samantha J. Busfield, Gino Vairo
The prognosis of older patients with acute myelogenous leukemia is generally poor. The interleukin-3 receptor alpha-chain (CD123) is highly expressed on the surface of acute leukemia cells compared with normal hematopoietic stem cells. CSL362 is a fu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56173a4e724bccf666f776b2e2fc1e9a
https://hdl.handle.net/11541.2/127184
https://hdl.handle.net/11541.2/127184
Autor:
Sridurga Mithraprabhu, Nicholas James Cummings, Andrew H. Wei, Anthony E. Dear, Peter Mollee, Peter J. Tan, Andrew Spencer, Michelle Perugini, Sushrut Patil, Richard J D'Andrea, Andrew Grigg, Patricia Walker, Sharon Avery, Hong Bin Liu, Kerry D Reed
Publikováno v:
Blood Cancer Journal
Presented in part at the 53rd Annual Meeting of the American Society of Hematology, San Diego, CA, December 10-13, 2011, and the 17th Congress of the European Haematology Association, Amsterdam, June 14-17, 2012. Therapeutic options are limited for e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::211e2f0cdf249dd6bed6f8ad5742a214
https://hdl.handle.net/1959.8/152527
https://hdl.handle.net/1959.8/152527